创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

WANG Shengfeng, ZHOU Wenhu. Progress of Research on Biomimetic DNAzyme for Tumor Theranostic Applications[J]. Progress in Pharmaceutical Sciences, 2021, 45(5): 363-371.
Citation: WANG Shengfeng, ZHOU Wenhu. Progress of Research on Biomimetic DNAzyme for Tumor Theranostic Applications[J]. Progress in Pharmaceutical Sciences, 2021, 45(5): 363-371.

Progress of Research on Biomimetic DNAzyme for Tumor Theranostic Applications

  • As a catalytic DNA molecule obtained by in vitro selection, DNAzyme has the advantages of high stability, good specificity, cost-effectiveness and no immunogenicity.Among DNAzymes, the one with RNA-cleavage activity mimics the function of ribozyme in biology, which has attracted particular attention for tumor theranostic applications.This paper describes the basic information of DNAzyme, including its screening process, the mechanism of RNA cleavage and the representative DNAzymes, and introduces the application of DNAzyme in RNA interference, tumor multi-model synergistic therapy, tumor theranostics and stimulus-responsive drug delivery, with a prospect of their potential applications in this field and future development so as to provide reference for the clinical translation of DNAzyme.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return